Today: 29 April 2026
Coca-Cola stock price climbs late as staples lead; Feb 10 earnings in focus
2 February 2026
1 min read

Coca-Cola stock price climbs late as staples lead; Feb 10 earnings in focus

New York, Feb 2, 2026, 15:53 (EST) — Regular session

  • Coca-Cola shares gained roughly 1% in late trading, beating the broader market.
  • Consumer staples led the gains, even as oil and gold funds slipped further.
  • Investors are eyeing Coca-Cola’s results on Feb. 10 and its CAGNY presentation set for Feb. 17.

The Coca-Cola Company’s shares edged up roughly 1% on Monday, closing in on $75.58 late in the New York trading session.

The uptick followed a surge in consumer staples, the market’s defensive segment covering food, beverages, and household items. The Consumer Staples Select Sector SPDR Fund gained roughly 1.3%, outpacing the S&P 500 ETF’s 0.5% rise, with PepsiCo climbing about 1.6%.

Volatility in commodities kept investors on edge. U.S. oil and gold funds dropped roughly 5.4% and 3.3%, respectively. The metal selloff has been steep enough to trigger position liquidation, analysts noted. “The scale of the unwind … is something I haven’t witnessed since the dark days of the 2008 global financial crisis,” said IG market analyst Tony Sycamore. Reuters

Wall Street climbed after a purchasing managers index (PMI) revealed that U.S. factory activity expanded in January for the first time in twelve months. “The fundamentals are good and earnings are strong,” said Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder. Reuters

Coca-Cola’s next major milestone is its earnings report. The company will release its fourth-quarter and full-year 2025 results before the New York Stock Exchange opens on Feb. 10. A conference call follows at 8:30 a.m. ET that day. Coca-Cola is also scheduled to speak at the Consumer Analyst Group of New York (CAGNY) conference on Feb. 17.

Investors are focused on whether demand is easing following price hikes in packaged food and drinks, and how much of Coca-Cola’s growth still depends on higher prices versus increased volume.

Currency remains a major headache. With much of Coca-Cola’s profit coming from abroad, a stronger dollar often drags down reported earnings when those foreign sales are converted back.

Dividend payers have found their way back onto the tape. That typically benefits Coca-Cola during market jitters, though it can turn against the company if investors shift toward faster-growth stocks and leave defensives in the dust.

The downside risk is clear. Should volumes fall short, particularly in North America, or if input costs surge alongside any commodity rebound, the stock could swiftly lose its “safe” status, even if revenue remains steady through pricing.

Traders are zeroing in on the Feb. 10 earnings and outlook. Then, all eyes turn to management’s remarks at CAGNY on Feb. 17, searching for any change in tone on demand, pricing, and costs.

Stock Market Today

  • Mesoblast Shares Falter Amid Growing Uncertainty Over Growth Prospects
    April 28, 2026, 10:58 PM EDT. Mesoblast (ASX:MSB) shares closed at A$2.15, down 6.5% over the past week despite a 0.5% gain in the last day. The biopharma firm shows mixed signals: positive 1- and 3-year shareholder returns contrast with weaker short-term performance. Analysts highlight Mesoblast as 43.9% undervalued with a fair value target of A$3.83, driven by heart failure drug rexlemestrocel L, pending potential U.S. accelerated FDA approval. However, risks loom from slow Ryoncil sales and trial delays. Valuation models conflict; discounted cash flow suggests undervaluation at A$3.05, but a high price-to-sales ratio of 30.5x versus industry norms raises questions if the market overpays for growth or if assumptions are overstretched. Investors remain cautious amid uncertain future earnings and regulatory hurdles.

Latest article

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

AST SpaceMobile Stock’s May 11 Moment: FCC Win Meets BlueBird 7 Reality

29 April 2026
AST SpaceMobile will hold its first-quarter update call on May 11 after winning FCC approval to deploy a 248-satellite constellation for direct-to-device service. Shares fell 6.8% Tuesday, following the loss of its BlueBird 7 satellite in a failed launch. The company expects insurance to cover the loss and is targeting 45 satellites in orbit by end-2026. Investors are watching launch progress and commercial service timing.
OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

OpenAI Target Miss Report Sends Oracle, CoreWeave and AI Stocks Lower

29 April 2026
Oracle shares fell 4% and CoreWeave dropped 5.9% Tuesday after a Wall Street Journal report said OpenAI missed recent revenue and user targets. Nvidia, AMD, and Arm Holdings also declined, with the iShares Semiconductor ETF down 3.7%. OpenAI denied internal divisions and said its AI coding product Codex reached 4 million users. Oracle’s credit default swaps hit a two-week high amid concern over its $300 billion cloud deal with OpenAI.
Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom
Previous Story

Nebius (NBIS) stock rebounds after a wild session as Feb. 12 results loom

JPMorgan stock rises after-hours as Fed loan-demand signal lifts banks — what to watch next
Next Story

JPMorgan stock rises after-hours as Fed loan-demand signal lifts banks — what to watch next

Go toTop